Search Results - gang+zhou

1 Results

Sort By:

Chimeric Antigen Receptor T Cells and Methods of Use Thereof

The current state of the art With four FDA-approved therapies (Axicabtagene ciloleucel, Brexucabtagene autoleucel, lisocabtagene maraleucel, and Tisagenlecleucel), the adoptive T cell (ACT) therapies’ market is attracting more investment. Although ACT has shown some successful clinical application, it has not been effective in treating most solid...

Published: 3/10/2021 | Inventor(s): Gang Zhou

Keywords(s):

Category(s): Therapeutics